Evidence map›Paper›PMID 40895631›Full record

ArticleFrontiers in endocrinology2025

Optimizing extended ablation margins in papillary thyroid carcinoma using digital pathology.

Han-Xiao Zhao, Yun Niu, Zhen-Long Zhao, Yu-Tong Liu, Ming-An Yu

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Han-Xiao ZhaoChina-Japan Friendship Institute of Clinical Medical Sciences, Beijing, China.
Yun NiuDepartment of Pathology, China-Japan Friendship Hospital, Beijing, China.
Zhen-Long ZhaoDepartment of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.
Yu-Tong LiuDepartment of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.
Ming-An YuDepartment of Interventional Medicine, China-Japan Friendship Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To reduce the risk of local recurrence of papillary thyroid carcinoma (PTC) after thermal ablation, in clinical practice, the ablation area is typically extended 2-3 mm beyond the original tumor margin. However, there is no definitive evidence to support the validity of this extended margin. Objective: The objective of this study was to measure the distance from the edge of a PTC to the farthest point of tumor infiltration using digital pathology and to analyze the associated risk factors. Methods: A total of 227 patients who underwent surgical resection for PTC were included in the study. The median age was 45 years. The slides with the maximum tumor diameter were selected as the target slides. Two authors independently assessed the characteristics of the PTCs and measured infiltration distances, with the greatest distance recorded as the infiltration distance. Risk factors associated with infiltration distance were analyzed using the rank-sum test, correlation analysis, and multiple linear regression. Results: Of the 227 tumors, 23 tumors showed no signs of infiltration; the remaining 204 tumors had infiltration distances ranging from 0.14 to 2.26 mm, with 3 tumors having distances greater than 2 mm (2.17, 2.19 and 2.26 mm). Significant differences in infiltration distances were observed in relation to maximum tumor diameter, lymph node metastases, and tumor growth patterns (TGPs) on the basis of the rank-sum test or correlation analyses. However, multiple linear regression analyses revealed that only TGPs were risk factors for infiltration distance. Conclusion: To minimize the risk of local recurrence of PTC following thermal ablation, extending the ablation margin by 2.5 mm is recommended, regardless of the tumor stage.

Indexed as

Margins of ExcisionNeoplasm Recurrence, LocalThyroid Cancer, PapillaryThyroid NeoplasmsAdolescentAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesThyroidectomyYoung Adultdigital pathologyextended ablation marginlocal recurrencepapillary thyroid carcinomathermal ablation

Identifiers

PMID40895631
PMCPMC12395501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.